TickerFactsScreenerDevelopers

GYRE THERAPEUTICS, INC. (GYRE) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $51.20M2009: $83.91M2010: $165.85M2011: $107.28M2012: $3.40M2013: $2.83M2014: $1.54M2015: $29.10M2016: $10.26M2017: $14.47M2018: $31.21M2019: $15.37M2020: $30.36M2021: $44.35M2022: $25.18M2023: $33.51M2024: $11.81M2025: $37.07M$37.07M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$37.07M+213.8%
2024$11.81M-64.7%
2023$33.51M+33.1%
2022$25.18M-43.2%
2021$44.35M+46.1%
2020$30.36M+97.5%
2019$15.37M-50.8%
2018$31.21M+115.7%
2017$14.47M+41.0%
2016$10.26M-64.7%
2015$29.10M+1784.5%
2014$1.54M-45.4%
2013$2.83M-16.8%
2012$3.40M-96.8%
2011$107.28M-35.3%
2010$165.85M+97.7%
2009$83.91M+63.9%
2008$51.20M—